InsiderDB
Sign inStart free trial

Becton, Dickinson and Company (BDX)

Healthcare · Medical - Instruments & Supplies

12 members of Congress have disclosed 26 trades in Becton, Dickinson and Company (BDX) since 2016: 15 buys and 11 sales. The most recent was disclosed on Oct 7, 2026. 3 trades were made by members of a committee that oversees Becton, Dickinson and Company's industry.

Trades disclosed
26
Members trading
12
Buys / sells
15 / 11
Reported value
$82K–$530K

Keep following the company.

Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.

Follow BDX

What else is happening at BDX

All research →

Company filings and public records connected to this stock, ordered by when they became public or were first observed.

  1. BDXContract award·SAM.gov

    6550--Micro Reagents and Service Contract

    Award notice naming BECTON, DICKINSON AND COMPANY. The notice amount is reported as stated; it is not a revenue forecast.

    Public: Nov 6, 2026Event / period: Aug 13, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  2. BDXContract award·SAM.gov

    6550--Micro Reagents and Service Contract

    Award notice naming BECTON, DICKINSON AND COMPANY. The notice amount is reported as stated; it is not a revenue forecast.

    Public: Nov 6, 2026Event / period: Aug 18, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  3. BDXCompany announcement·SEC EDGAR

    BDX: Financial results

    Filed 8-K for an event or period dated 2026-11-05. Financial results.

    Public: Nov 5, 2026, 6:31 AM ESTEvent / period: Nov 5, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  4. BDXLobbying report·Lobbying disclosures

    BDX: first_quarter 2026 lobbying report

    Issues related to corporate taxation Tax incentives for domestic manufacturing Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to medical device sterilization Issues related to medical device supply chain Issues related to international trade Issues related to reimbursement Issues related to CY2026 Home Health and DMEPOS PPS proposed rule and ANPRM on PPE and essential medicines Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues rel

    Public: Oct 20, 2026, 6:55 PM EDTOriginal source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  5. BDXLobbying report·Lobbying disclosures

    BDX: third_quarter 2026 lobbying report

    Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to maternal health Issues related to corporate taxation Tax incentives for domestic manufacturing Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to the National Defense Authorization Act Issues related to international trade Issues related to medical device supply chain & Section 232 National Security Investigation into med

    Public: Oct 20, 2026, 6:53 PM EDTOriginal source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

Committee overlaps

Trades by members of a committee that oversees Becton, Dickinson and Company's industry. An overlap is a fact about the trade, not evidence of wrongdoing.

Who traded BDX

All trades

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.